ライフサイエンスコーパス: poliovirus receptor

1 ne response in mice transgenic for the human poliovirus receptor.

2 ng pathogenicity, in mice transgenic for the poliovirus receptor.

3 ells (Neuro-2a(CD155)) expressing CD155, the poliovirus receptor.

4 a transgenic mouse line expressing the human poliovirus receptor.

5 s uses nectin-like 5 (necl-5), also known as poliovirus receptor.

6 erts immunosuppressive effects by binding to poliovirus receptor and modulating cytokine production b

7 18) but not Mac-1 (CD11b/CD18); nectin-2 and poliovirus receptor are engaged by both DNAX accessory m

8 tified the immunoglobulin-CAM CD155/PVR (the poliovirus receptor) as a regulator of cancer invasivene

9 canyon at sites that extensively overlap the poliovirus receptor-binding site.

10 Treatment with a poliovirus receptor-blocking antibody phenocopied the pr

11 TuAg1/TagE4, the rat ortholog of the human poliovirus receptor CD155, is expressed on a high percen

12 s previously shown to interact with cellular poliovirus receptor CD155.

13 PECAM-1 and depends on nectin-2 (CD112) and poliovirus receptor (CD155) as well as EC ICAM-1.

14 structure of the extracellular, three-domain poliovirus receptor (CD155) complexed with poliovirus (s

15 The expression of the human poliovirus receptor (CD155) within gastrointestinal-asso

16 platelet/endothelial cell adhesion molecule, poliovirus receptor (CD155), and CD99.

17 ein intermediate chain, Fyn, DOC2, FIP1, the poliovirus receptor, CD155, and the rhodopsin cytoplasmi

18 oliovirus may be mediated by expression of a poliovirus receptor, CD155, in glial neoplasms.

19 onatal but not adult mice transgenic for the poliovirus receptor, CD155.

20 The human poliovirus receptor/CD155 is a transmembrane glycoprotei

21 sal expression of the MICB and DNAM-1 ligand poliovirus receptor/CD155.

22 viral capsid, as predicted by a model of the poliovirus-receptor complex.

23 intained during viral spread to the brain of poliovirus receptor-expressing mice.

24 da that bound to HAVCR1/TIM1 Fc but not to a poliovirus receptor Fc fusion protein in a capture enzym

25 adhesion molecule encoded by a member of the poliovirus receptor gene family.

26 uperfamily, originally designated the murine poliovirus receptor homolog (Mph), was found to be a rec

27 ility of inactivated PV to bind to the human poliovirus receptor (hPVR) using various techniques such

28 (135S) could interact with membranes lacking poliovirus receptors in an effort to begin to understand

29 points toward a critical role for CD155, the poliovirus receptor, in suppressing T cell function, par

30 genetic analyses have been used to study the poliovirus-receptor interaction: (i) mutagenesis of the

31 nsertional mutagenesis screen, we identified poliovirus receptor-like 3 (PVRL3) as a cellular factor

32 and the adherens junction protein nectin-4 (poliovirus receptor-like 4 [PVRL4]) as receptors.

33 e identified a cell adhesion molecule PVRL4 (poliovirus-receptor-like 4), also known as Nectin-4.

34 tes the results of 37 degrees C warming of a poliovirus-receptor-liposome model complex that was prod

35 ue to widespread ectopic upregulation of the poliovirus receptor, Necl-5, in ectodermal/neuroectoderm

36 We examined the role of soluble poliovirus receptor on the transition of native poliovir

37 Transcripts encoding the monkey poliovirus receptors originate from a region analogous t

38 The poliovirus receptor (PVR) belongs to a large family of I

39 find that the binding site overlaps with the poliovirus receptor (PVR) binding site and maps across a

40 olated transgenic mice which carry the human poliovirus receptor (PVR) gene (TgPVR mice), which devel

41 The poliovirus receptor (PVR) is a ubiquitously expressed gl

42 Poliovirus receptor (Pvr) itself mediated entry of PRV a

43 Poliovirus receptor (PVR) ligands have gained attention

44 Expression of the poliovirus receptor (PVR) on cells is a major host deter

45 Transgenic (Tg) mice expressing the human poliovirus receptor (PVR) were vaccinated with inactivat

46 aspinally inoculated mice transgenic for the poliovirus receptor (PVR) with replicons encoding murine

47 receptor interaction: (i) mutagenesis of the poliovirus receptor (PVR), (ii) selection of viral mutan

48 Upon binding to the poliovirus receptor (PVR), the poliovirus 160S particles

49 three different mutations in domain 1 of the poliovirus receptor (Pvr), two in the predicted C'-C" ri

50 ULBP)1-6 (NKG2D ligand), Nectin-2/CD112, and poliovirus receptor (PVR)/CD155 (DNAM-1 ligand), are oft

51 Here, we report the crystal structure of poliovirus receptor (PVR)/Nectin-like-5/CD155) in comple

52 IgG1 to D1 (D1-Fc) or the ectodomain of the poliovirus receptor (PVR-Fc) and expressed them in CHO c

53 cells and monocytes with antibodies against poliovirus receptor (PVR; CD155) and DNAX-associated mol

54 The DNAM-1 ligands Nectin-2 (CD112) and the poliovirus receptor (PVR; CD155) were expressed by most

55 s entry mediator C (HveC), also known as the poliovirus receptor-related protein 1 (PRR1) and as nect

56 This membrane glycoprotein is poliovirus receptor-related protein 1 (Prr1), designated

57 omolog of human nectin-1alpha (also known as poliovirus receptor-related protein 1 [Prr1] and herpesv

58 s, the one designated HveB and also known as poliovirus receptor-related protein 2.

59 necrosis factor receptor family, whereas the poliovirus receptor-related proteins 1 and 2 (PRR1 and P

60 it could play a role in the function of the poliovirus receptor site.

61 using transgenic mouse expressing the human poliovirus receptor (Tg21-PVR) mice, and their antigenic

62 The binding of poliovirus receptor to TIGIT on human dendritic cells en

63 and equilibrium of poliovirus binding to the poliovirus receptor, we used surface plasmon resonance t

64 Poliovirus receptor, which is expressed on dendritic cel